APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Avastin (Bevacizumab) Biosimilars

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Avastin (Bevacizumab) Biosimilars Industry Growth and Trends Forecast to 2032

Report ID 173968440129 December 2025127 pages

Choose your research edition.

Industry ResearchAvastin (Bevacizumab) Biosimilars Industry Research Report 2026149 pages · $2,950 USDIndustry Growth & TrendsGlobal Avastin (Bevacizumab) Biosimilars Industry Growth and Trends Forecast to 2032127 pages · $3,450 USDMarket StructureGlobal Avastin (Bevacizumab) Biosimilars Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Avastin (Bevacizumab) Biosimilars Market Outlook and Growth Opportunities 2026218 pages · $4,250 USDMarket Analysis & ForecastGlobal Avastin (Bevacizumab) Biosimilars Market Analysis and Forecast 2026-2032212 pages · $4,950 USD

Market perspective

The global Avastin (Bevacizumab) Biosimilars market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Avastin (Bevacizumab) Biosimilars is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Avastin (Bevacizumab) Biosimilars is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Avastin (Bevacizumab) Biosimilars is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Avastin (Bevacizumab) Biosimilars include Biocad, Biocon, Cadila Pharmaceuticals, Centus, Dr Reddy's, Genentech, Hetero, Kirin Biologics and MAbxience, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Avastin (Bevacizumab) Biosimilars market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Avastin (Bevacizumab) Biosimilars market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Avastin (Bevacizumab) Biosimilars market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Avastin (Bevacizumab) Biosimilars.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Avastin (Bevacizumab) Biosimilars market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Avastin (Bevacizumab) Biosimilars Market by Company

Biocad

Biocon

Cadila Pharmaceuticals

Centus

Dr Reddy's

Genentech

Hetero

Kirin Biologics

MAbxience

PharmaPraxis

PlantForm

Samsung Bioepis

Sartorius

Amgen

BeiGene

Bayer

TOT BIOPHARM

Henlius

Pfizer

Eli Lilly

Roche

Luye Pharmaceutical

Mylan

Qilu Pharmaceutical

Innovent

Avastin (Bevacizumab) Biosimilars Segment by Type

Cancers

AMD

Avastin (Bevacizumab) Biosimilars Segment by Application

Hospitals

Clinics

Others

Avastin (Bevacizumab) Biosimilars Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Avastin (Bevacizumab) Biosimilars market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Avastin (Bevacizumab) Biosimilars and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Avastin (Bevacizumab) Biosimilars.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Avastin (Bevacizumab) Biosimilars manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Avastin (Bevacizumab) Biosimilars in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Cancers Table 2. Major Company of AMD Table 3. Global Avastin (Bevacizumab) Biosimilars Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Avastin (Bevacizumab) Biosimilars Sales by Type (2021-2026) & (K Units) Table 5. Global Avastin (Bevacizumab) Biosimilars Sales Market Share in Volume by Type (2021-2026) Table 6. Global Avastin (Bevacizumab) Biosimilars Sales by Type (2021-2026) & (US$ Million) Table 7. Global Avastin (Bevacizumab) Biosimilars Sales Market Share in Value by Type (2021-2026) Table 8. Global Avastin (Bevacizumab) Biosimilars Price by Type (2021-2026) & (US$/Unit) Table 9. Global Avastin (Bevacizumab) Biosimilars Sales by Type (2027-2032) & (K Units) Table 10. Global Avastin (Bevacizumab) Biosimilars Sales Market Share in Volume by Type (2027-2032) Table 11. Global Avastin (Bevacizumab) Biosimilars Sales by Type (2027-2032) & (US$ Million) Table 12. Global Avastin (Bevacizumab) Biosimilars Sales Market Share in Value by Type (2027-2032) Table 13. Global Avastin (Bevacizumab) Biosimilars Price by Type (2027-2032) & (US$/Unit) Table 14. North America Avastin (Bevacizumab) Biosimilars Sales by Type (2021-2026) & (K Units) Table 15. North America Avastin (Bevacizumab) Biosimilars Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Avastin (Bevacizumab) Biosimilars Sales by Type (2021-2026) & (K Units) Table 17. Europe Avastin (Bevacizumab) Biosimilars Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Avastin (Bevacizumab) Biosimilars Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Avastin (Bevacizumab) Biosimilars Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Avastin (Bevacizumab) Biosimilars Sales by Type (2021-2026) & (K Units) Table 21. Latin America Avastin (Bevacizumab) Biosimilars Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Avastin (Bevacizumab) Biosimilars Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Avastin (Bevacizumab) Biosimilars Sales by Type (2021-2026) & (US$ Million) Table 24. Avastin (Bevacizumab) Biosimilars Industry Trends Table 25. Avastin (Bevacizumab) Biosimilars Industry Drivers Table 26. Avastin (Bevacizumab) Biosimilars Industry Opportunities and Challenges Table 27. Avastin (Bevacizumab) Biosimilars Industry Restraints Table 28. Global Avastin (Bevacizumab) Biosimilars Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Avastin (Bevacizumab) Biosimilars Revenue Market Share by Company (2021-2026) Table 30. Global Avastin (Bevacizumab) Biosimilars Sales by Company (2021-2026) & (K Units) Table 31. Global Avastin (Bevacizumab) Biosimilars Sales Share by Company (2021-2026) Table 32. Global Avastin (Bevacizumab) Biosimilars Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Avastin (Bevacizumab) Biosimilars Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Avastin (Bevacizumab) Biosimilars Major Company Production Sites and Headquarters Table 35. Global Avastin (Bevacizumab) Biosimilars Company, Product Type & Application Table 36. Global Avastin (Bevacizumab) Biosimilars Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Avastin (Bevacizumab) Biosimilars by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Avastin (Bevacizumab) Biosimilars Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Avastin (Bevacizumab) Biosimilars Sales by Region (2021-2026) & (K Units) Table 41. Global Avastin (Bevacizumab) Biosimilars Sales Market Share in Volume by Region (2021-2026) Table 42. Global Avastin (Bevacizumab) Biosimilars Sales by Region (2021-2026) & (US$ Million) Table 43. Global Avastin (Bevacizumab) Biosimilars Sales Market Share in Value by Region (2021-2026) Table 44. Global Avastin (Bevacizumab) Biosimilars Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Avastin (Bevacizumab) Biosimilars Sales by Region (2027-2032) & (K Units) Table 46. Global Avastin (Bevacizumab) Biosimilars Sales Market Share in Volume by Region (2027-2032) Table 47. Global Avastin (Bevacizumab) Biosimilars Sales by Region (2027-2032) & (US$ Million) Table 48. Global Avastin (Bevacizumab) Biosimilars Sales Market Share in Value by Region (2027-2032) Table 49. Global Avastin (Bevacizumab) Biosimilars Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Avastin (Bevacizumab) Biosimilars Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Avastin (Bevacizumab) Biosimilars Sales by Application (2021-2026) & (K Units) Table 52. Global Avastin (Bevacizumab) Biosimilars Sales Market Share in Volume by Application (2021-2026) Table 53. Global Avastin (Bevacizumab) Biosimilars Sales by Application (2021-2026) & (US$ Million) Table 54. Global Avastin (Bevacizumab) Biosimilars Sales Market Share in Value by Application (2021-2026) Table 55. Global Avastin (Bevacizumab) Biosimilars Price by Application (2021-2026) & (US$/Unit) Table 56. Global Avastin (Bevacizumab) Biosimilars Sales by Application (2027-2032) & (K Units) Table 57. Global Avastin (Bevacizumab) Biosimilars Sales Market Share in Volume by Application (2027-2032) Table 58. Global Avastin (Bevacizumab) Biosimilars Sales by Application (2027-2032) & (US$ Million) Table 59. Global Avastin (Bevacizumab) Biosimilars Sales Market Share in Value by Application (2027-2032) Table 60. Global Avastin (Bevacizumab) Biosimilars Price by Application (2027-2032) & (US$/Unit) Table 61. North America Avastin (Bevacizumab) Biosimilars Sales by Application (2021-2026) & (K Units) Table 62. North America Avastin (Bevacizumab) Biosimilars Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Avastin (Bevacizumab) Biosimilars Sales by Application (2021-2026) & (K Units) Table 64. Europe Avastin (Bevacizumab) Biosimilars Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Avastin (Bevacizumab) Biosimilars Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Avastin (Bevacizumab) Biosimilars Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Avastin (Bevacizumab) Biosimilars Sales by Application (2021-2026) & (K Units) Table 68. Latin America Avastin (Bevacizumab) Biosimilars Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Avastin (Bevacizumab) Biosimilars Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Avastin (Bevacizumab) Biosimilars Sales by Application (2021-2026) & (US$ Million) Table 71. Biocad Company Information Table 72. Biocad Business Overview Table 73. Biocad Avastin (Bevacizumab) Biosimilars Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Biocad Avastin (Bevacizumab) Biosimilars Product Portfolio Table 75. Biocad Recent Development Table 76. Biocon Company Information Table 77. Biocon Business Overview Table 78. Biocon Avastin (Bevacizumab) Biosimilars Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Biocon Avastin (Bevacizumab) Biosimilars Product Portfolio Table 80. Biocon Recent Development Table 81. Cadila Pharmaceuticals Company Information Table 82. Cadila Pharmaceuticals Business Overview Table 83. Cadila Pharmaceuticals Avastin (Bevacizumab) Biosimilars Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Cadila Pharmaceuticals Avastin (Bevacizumab) Biosimilars Product Portfolio Table 85. Cadila Pharmaceuticals Recent Development Table 86. Centus Company Information Table 87. Centus Business Overview Table 88. Centus Avastin (Bevacizumab) Biosimilars Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Centus Avastin (Bevacizumab) Biosimilars Product Portfolio Table 90. Centus Recent Development Table 91. Dr Reddy's Company Information Table 92. Dr Reddy's Business Overview Table 93. Dr Reddy's Avastin (Bevacizumab) Biosimilars Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Dr Reddy's Avastin (Bevacizumab) Biosimilars Product Portfolio Table 95. Dr Reddy's Recent Development Table 96. Genentech Company Information Table 97. Genentech Business Overview Table 98. Genentech Avastin (Bevacizumab) Biosimilars Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Genentech Avastin (Bevacizumab) Biosimilars Product Portfolio Table 100. Genentech Recent Development Table 101. Hetero Company Information Table 102. Hetero Business Overview Table 103. Hetero Avastin (Bevacizumab) Biosimilars Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Hetero Avastin (Bevacizumab) Biosimilars Product Portfolio Table 105. Hetero Recent Development Table 106. Kirin Biologics Company Information Table 107. Kirin Biologics Business Overview Table 108. Kirin Biologics Avastin (Bevacizumab) Biosimilars Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Kirin Biologics Avastin (Bevacizumab) Biosimilars Product Portfolio Table 110. Kirin Biologics Recent Development Table 111. MAbxience Company Information Table 112. MAbxience Business Overview Table 113. MAbxience Avastin (Bevacizumab) Biosimilars Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. MAbxience Avastin (Bevacizumab) Biosimilars Product Portfolio Table 115. MAbxience Recent Development Table 116. PharmaPraxis Company Information Table 117. PharmaPraxis Business Overview Table 118. PharmaPraxis Avastin (Bevacizumab) Biosimilars Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. PharmaPraxis Avastin (Bevacizumab) Biosimilars Product Portfolio Table 120. PharmaPraxis Recent Development Table 121. PlantForm Company Information Table 122. PlantForm Business Overview Table 123. PlantForm Avastin (Bevacizumab) Biosimilars Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. PlantForm Avastin (Bevacizumab) Biosimilars Product Portfolio Table 125. PlantForm Recent Development Table 126. Samsung Bioepis Company Information Table 127. Samsung Bioepis Business Overview Table 128. Samsung Bioepis Avastin (Bevacizumab) Biosimilars Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 129. Samsung Bioepis Avastin (Bevacizumab) Biosimilars Product Portfolio Table 130. Samsung Bioepis Recent Development Table 131. Sartorius Company Information Table 132. Sartorius Business Overview Table 133. Sartorius Avastin (Bevacizumab) Biosimilars Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 134. Sartorius Avastin (Bevacizumab) Biosimilars Product Portfolio Table 135. Sartorius Recent Development Table 136. Amgen Company Information Table 137. Amgen Business Overview Table 138. Amgen Avastin (Bevacizumab) Biosimilars Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 139. Amgen Avastin (Bevacizumab) Biosimilars Product Portfolio Table 140. Amgen Recent Development Table 141. BeiGene Company Information Table 142. BeiGene Business Overview Table 143. BeiGene Avastin (Bevacizumab) Biosimilars Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 144. BeiGene Avastin (Bevacizumab) Biosimilars Product Portfolio Table 145. BeiGene Recent Development Table 146. Bayer Company Information Table 147. Bayer Business Overview Table 148. Bayer Avastin (Bevacizumab) Biosimilars Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 149. Bayer Avastin (Bevacizumab) Biosimilars Product Portfolio Table 150. Bayer Recent Development Table 151. TOT BIOPHARM Company Information Table 152. TOT BIOPHARM Business Overview Table 153. TOT BIOPHARM Avastin (Bevacizumab) Biosimilars Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 154. TOT BIOPHARM Avastin (Bevacizumab) Biosimilars Product Portfolio Table 155. TOT BIOPHARM Recent Development Table 156. Henlius Company Information Table 157. Henlius Business Overview Table 158. Henlius Avastin (Bevacizumab) Biosimilars Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 159. Henlius Avastin (Bevacizumab) Biosimilars Product Portfolio Table 160. Henlius Recent Development Table 161. Pfizer Company Information Table 162. Pfizer Business Overview Table 163. Pfizer Avastin (Bevacizumab) Biosimilars Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 164. Pfizer Avastin (Bevacizumab) Biosimilars Product Portfolio Table 165. Pfizer Recent Development Table 166. Eli Lilly Company Information Table 167. Eli Lilly Business Overview Table 168. Eli Lilly Avastin (Bevacizumab) Biosimilars Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 169. Eli Lilly Avastin (Bevacizumab) Biosimilars Product Portfolio Table 170. Eli Lilly Recent Development Table 171. Roche Company Information Table 172. Roche Business Overview Table 173. Roche Avastin (Bevacizumab) Biosimilars Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 174. Roche Avastin (Bevacizumab) Biosimilars Product Portfolio Table 175. Roche Recent Development Table 176. Luye Pharmaceutical Company Information Table 177. Luye Pharmaceutical Business Overview Table 178. Luye Pharmaceutical Avastin (Bevacizumab) Biosimilars Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 179. Luye Pharmaceutical Avastin (Bevacizumab) Biosimilars Product Portfolio Table 180. Luye Pharmaceutical Recent Development Table 181. Mylan Company Information Table 182. Mylan Business Overview Table 183. Mylan Avastin (Bevacizumab) Biosimilars Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 184. Mylan Avastin (Bevacizumab) Biosimilars Product Portfolio Table 185. Mylan Recent Development Table 186. Qilu Pharmaceutical Company Information Table 187. Qilu Pharmaceutical Business Overview Table 188. Qilu Pharmaceutical Avastin (Bevacizumab) Biosimilars Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 189. Qilu Pharmaceutical Avastin (Bevacizumab) Biosimilars Product Portfolio Table 190. Qilu Pharmaceutical Recent Development Table 191. Innovent Company Information Table 192. Innovent Business Overview Table 193. Innovent Avastin (Bevacizumab) Biosimilars Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 194. Innovent Avastin (Bevacizumab) Biosimilars Product Portfolio Table 195. Innovent Recent Development Table 196. North America Avastin (Bevacizumab) Biosimilars Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 197. North America Avastin (Bevacizumab) Biosimilars Sales by Country (2021-2026) & (K Units) Table 198. North America Avastin (Bevacizumab) Biosimilars Sales Market Share by Country (2021-2026) Table 199. North America Avastin (Bevacizumab) Biosimilars Sales Forecast by Country (2027-2032) & (K Units) Table 200. North America Avastin (Bevacizumab) Biosimilars Sales Market Share Forecast by Country (2027-2032) Table 201. North America Avastin (Bevacizumab) Biosimilars Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 202. North America Avastin (Bevacizumab) Biosimilars Market Size by Country (2021-2026) & (US$ Million) Table 203. North America Avastin (Bevacizumab) Biosimilars Market Share by Country (2021-2026) Table 204. North America Avastin (Bevacizumab) Biosimilars Market Size Forecast by Country (2027-2032) & (US$ Million) Table 205. North America Avastin (Bevacizumab) Biosimilars Market Share Forecast by Country (2027-2032) Table 206. Europe Avastin (Bevacizumab) Biosimilars Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 207. Europe Avastin (Bevacizumab) Biosimilars Sales by Country (2021-2026) & (K Units) Table 208. Europe Avastin (Bevacizumab) Biosimilars Sales Market Share by Country (2021-2026) Table 209. Europe Avastin (Bevacizumab) Biosimilars Sales Forecast by Country (2027-2032) & (K Units) Table 210. Europe Avastin (Bevacizumab) Biosimilars Sales Market Share Forecast by Country (2027-2032) Table 211. Europe Avastin (Bevacizumab) Biosimilars Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 212. Europe Avastin (Bevacizumab) Biosimilars Market Size by Country (2021-2026) & (US$ Million) Table 213. Europe Avastin (Bevacizumab) Biosimilars Market Share by Country (2021-2026) Table 214. Europe Avastin (Bevacizumab) Biosimilars Market Size Forecast by Country (2027-2032) & (US$ Million) Table 215. Europe Avastin (Bevacizumab) Biosimilars Market Share Forecast by Country (2027-2032) Table 216. Asia-Pacific Avastin (Bevacizumab) Biosimilars Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 217. Asia-Pacific Avastin (Bevacizumab) Biosimilars Sales by Country (2021-2026) & (K Units) Table 218. Asia-Pacific Avastin (Bevacizumab) Biosimilars Sales Market Share by Country (2021-2026) Table 219. Asia-Pacific Avastin (Bevacizumab) Biosimilars Sales Forecast by Country (2027-2032) & (K Units) Table 220. Asia-Pacific Avastin (Bevacizumab) Biosimilars Sales Market Share Forecast by Country (2027-2032) Table 221. Asia-Pacific Avastin (Bevacizumab) Biosimilars Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 222. Asia-Pacific Avastin (Bevacizumab) Biosimilars Market Size by Country (2021-2026) & (US$ Million) Table 223. Asia-Pacific Avastin (Bevacizumab) Biosimilars Market Share by Country (2021-2026) Table 224. Asia-Pacific Avastin (Bevacizumab) Biosimilars Market Size Forecast by Country (2027-2032) & (US$ Million) Table 225. Asia-Pacific Avastin (Bevacizumab) Biosimilars Market Share Forecast by Country (2027-2032) Table 226. Latin America Avastin (Bevacizumab) Biosimilars Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 227. Latin America Avastin (Bevacizumab) Biosimilars Sales by Country (2021-2026) & (K Units) Table 228. Latin America Avastin (Bevacizumab) Biosimilars Sales Market Share by Country (2021-2026) Table 229. Latin America Avastin (Bevacizumab) Biosimilars Sales Forecast by Country (2027-2032) & (K Units) Table 230. Latin America Avastin (Bevacizumab) Biosimilars Sales Market Share Forecast by Country (2027-2032) Table 231. Latin America Avastin (Bevacizumab) Biosimilars Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 232. Latin America Avastin (Bevacizumab) Biosimilars Market Size by Country (2021-2026) & (US$ Million) Table 233. Latin America Avastin (Bevacizumab) Biosimilars Market Share by Country (2021-2026) Table 234. Latin America Avastin (Bevacizumab) Biosimilars Market Size Forecast by Country (2027-2032) & (US$ Million) Table 235. Latin America Avastin (Bevacizumab) Biosimilars Market Share Forecast by Country (2027-2032) Table 236. Middle East and Africa Avastin (Bevacizumab) Biosimilars Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 237. Middle East and Africa Avastin (Bevacizumab) Biosimilars Sales by Country (2021-2026) & (K Units) Table 238. Middle East and Africa Avastin (Bevacizumab) Biosimilars Sales Market Share by Country (2021-2026) Table 239. Middle East and Africa Avastin (Bevacizumab) Biosimilars Sales Forecast by Country (2027-2032) & (K Units) Table 240. Middle East and Africa Avastin (Bevacizumab) Biosimilars Sales Market Share Forecast by Country (2027-2032) Table 241. Middle East and Africa Avastin (Bevacizumab) Biosimilars Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 242. Middle East and Africa Avastin (Bevacizumab) Biosimilars Market Size by Country (2021-2026) & (US$ Million) Table 243. Middle East and Africa Avastin (Bevacizumab) Biosimilars Market Share by Country (2021-2026) Table 244. Middle East and Africa Avastin (Bevacizumab) Biosimilars Market Size Forecast by Country (2027-2032) & (US$ Million) Table 245. Middle East and Africa Avastin (Bevacizumab) Biosimilars Market Share Forecast by Country (2027-2032) Table 246. Key Raw Materials Table 247. Raw Materials Key Suppliers Table 248. Avastin (Bevacizumab) Biosimilars Distributors List Table 249. Avastin (Bevacizumab) Biosimilars Customers List Table 250. Research Programs/Design for This Report Table 251. Authors List of This Report Table 252. Secondary Sources Table 253. Primary Sources List of Figures Figure 1. Avastin (Bevacizumab) Biosimilars Image Figure 2. Global Avastin (Bevacizumab) Biosimilars Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Avastin (Bevacizumab) Biosimilars Market Size (2021-2032) & (US$ Million) Figure 4. Global Avastin (Bevacizumab) Biosimilars Sales (2021-2032) & (K Units) Figure 5. Cancers Image Figure 6. Global Cancers Sales YoY Growth (2021-2032) & (K Units) Figure 7. AMD Image Figure 8. Global AMD Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Avastin (Bevacizumab) Biosimilars Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Avastin (Bevacizumab) Biosimilars Market Share by Type 2025 VS 2032 Figure 11. North America Avastin (Bevacizumab) Biosimilars Sales Market Share in Volume by Type in 2025 Figure 12. North America Avastin (Bevacizumab) Biosimilars Sales Market Share in Value by Type in 2025 Figure 13. Europe Avastin (Bevacizumab) Biosimilars Sales Market Share in Volume by Type in 2025 Figure 14. Europe Avastin (Bevacizumab) Biosimilars Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Avastin (Bevacizumab) Biosimilars Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Avastin (Bevacizumab) Biosimilars Sales Market Share in Value by Type in 2025 Figure 17. Latin America Avastin (Bevacizumab) Biosimilars Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Avastin (Bevacizumab) Biosimilars Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Avastin (Bevacizumab) Biosimilars Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Avastin (Bevacizumab) Biosimilars Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Avastin (Bevacizumab) Biosimilars Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hospitals Image Figure 24. Global Hospitals Sales YoY Growth (2021-2032) & (K Units) Figure 25. Clinics Image Figure 26. Global Clinics Sales YoY Growth (2021-2032) & (K Units) Figure 27. Others Image Figure 28. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 29. Global Avastin (Bevacizumab) Biosimilars Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Avastin (Bevacizumab) Biosimilars Market Share by Application 2025 VS 2032 Figure 31. North America Avastin (Bevacizumab) Biosimilars Sales Market Share in Volume by Application in 2025 Figure 32. North America Avastin (Bevacizumab) Biosimilars Sales Market Share in Value by Application in 2025 Figure 33. Europe Avastin (Bevacizumab) Biosimilars Sales Market Share in Volume by Application in 2025 Figure 34. Europe Avastin (Bevacizumab) Biosimilars Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Avastin (Bevacizumab) Biosimilars Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Avastin (Bevacizumab) Biosimilars Sales Market Share in Value by Application in 2025 Figure 37. Latin America Avastin (Bevacizumab) Biosimilars Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Avastin (Bevacizumab) Biosimilars Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Avastin (Bevacizumab) Biosimilars Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Avastin (Bevacizumab) Biosimilars Sales Market Share in Value by Application in 2025 Figure 41. North America Avastin (Bevacizumab) Biosimilars Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 42. North America Avastin (Bevacizumab) Biosimilars Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Avastin (Bevacizumab) Biosimilars Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Avastin (Bevacizumab) Biosimilars Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Avastin (Bevacizumab) Biosimilars Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. Europe Avastin (Bevacizumab) Biosimilars Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Avastin (Bevacizumab) Biosimilars Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Avastin (Bevacizumab) Biosimilars Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Avastin (Bevacizumab) Biosimilars Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Asia-Pacific Avastin (Bevacizumab) Biosimilars Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Avastin (Bevacizumab) Biosimilars Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Avastin (Bevacizumab) Biosimilars Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Avastin (Bevacizumab) Biosimilars Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Latin America Avastin (Bevacizumab) Biosimilars Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Avastin (Bevacizumab) Biosimilars Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Avastin (Bevacizumab) Biosimilars Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Avastin (Bevacizumab) Biosimilars Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Middle East and Africa Avastin (Bevacizumab) Biosimilars Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Avastin (Bevacizumab) Biosimilars Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Avastin (Bevacizumab) Biosimilars Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Avastin (Bevacizumab) Biosimilars Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Avastin (Bevacizumab) Biosimilars Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Cancers
  • AMD
Applications
  • Hospitals
  • Clinics
  • Others
Companies covered
  • Biocad
  • Biocon
  • Cadila Pharmaceuticals
  • Centus
  • Dr Reddy's
  • Genentech
  • Hetero
  • Kirin Biologics
  • MAbxience
  • PharmaPraxis
  • PlantForm
  • Samsung Bioepis
  • Sartorius
  • Amgen
  • BeiGene
  • Bayer
  • TOT BIOPHARM
  • Henlius
  • Pfizer
  • Eli Lilly
  • Roche
  • Luye Pharmaceutical
  • Mylan
  • Qilu Pharmaceutical
  • Innovent

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Avastin (Bevacizumab) Biosimilars Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Avastin (Bevacizumab) Biosimilars Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Avastin (Bevacizumab) Biosimilars Market by Type
  6. 1.3.1 Cancers
  7. 1.3.2 AMD
  8. 1.4 Global Avastin (Bevacizumab) Biosimilars Market Size by Type
  9. 1.4.1 Global Avastin (Bevacizumab) Biosimilars Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Avastin (Bevacizumab) Biosimilars Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Avastin (Bevacizumab) Biosimilars Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Avastin (Bevacizumab) Biosimilars Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Avastin (Bevacizumab) Biosimilars Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Avastin (Bevacizumab) Biosimilars Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Avastin (Bevacizumab) Biosimilars Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Avastin (Bevacizumab) Biosimilars Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Avastin (Bevacizumab) Biosimilars Industry Trends
  2. 2.2 Avastin (Bevacizumab) Biosimilars Industry Drivers
  3. 2.3 Avastin (Bevacizumab) Biosimilars Industry Opportunities and Challenges
  4. 2.4 Avastin (Bevacizumab) Biosimilars Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Avastin (Bevacizumab) Biosimilars Revenue (2021-2026)
  2. 3.2 Global Top Players by Avastin (Bevacizumab) Biosimilars Sales (2021-2026)
  3. 3.3 Global Top Players by Avastin (Bevacizumab) Biosimilars Price (2021-2026)
  4. 3.4 Global Avastin (Bevacizumab) Biosimilars Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Avastin (Bevacizumab) Biosimilars Major Company Production Sites & Headquarters
  6. 3.6 Global Avastin (Bevacizumab) Biosimilars Company, Product Type & Application
  7. 3.7 Global Avastin (Bevacizumab) Biosimilars Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Avastin (Bevacizumab) Biosimilars Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Avastin (Bevacizumab) Biosimilars Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Avastin (Bevacizumab) Biosimilars Tier 1, Tier 2, and Tier 3
4 Avastin (Bevacizumab) Biosimilars Regional Status and Outlook
  1. 4.1 Global Avastin (Bevacizumab) Biosimilars Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Avastin (Bevacizumab) Biosimilars Historic Market Size by Region
  3. 4.2.1 Global Avastin (Bevacizumab) Biosimilars Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Avastin (Bevacizumab) Biosimilars Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Avastin (Bevacizumab) Biosimilars Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Avastin (Bevacizumab) Biosimilars Forecasted Market Size by Region
  7. 4.3.1 Global Avastin (Bevacizumab) Biosimilars Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Avastin (Bevacizumab) Biosimilars Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Avastin (Bevacizumab) Biosimilars Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Avastin (Bevacizumab) Biosimilars by Application
  1. 5.1 Avastin (Bevacizumab) Biosimilars Market by Application
  2. 5.1.1 Hospitals
  3. 5.1.2 Clinics
  4. 5.1.3 Others
  5. 5.2 Global Avastin (Bevacizumab) Biosimilars Market Size by Application
  6. 5.2.1 Global Avastin (Bevacizumab) Biosimilars Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Avastin (Bevacizumab) Biosimilars Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Avastin (Bevacizumab) Biosimilars Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Avastin (Bevacizumab) Biosimilars Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Avastin (Bevacizumab) Biosimilars Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Avastin (Bevacizumab) Biosimilars Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Avastin (Bevacizumab) Biosimilars Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Avastin (Bevacizumab) Biosimilars Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Biocad
  2. 6.1.1 Biocad Company Information
  3. 6.1.2 Biocad Business Overview
  4. 6.1.3 Biocad Avastin (Bevacizumab) Biosimilars Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Biocad Avastin (Bevacizumab) Biosimilars Product Portfolio
  6. 6.1.5 Biocad Recent Developments
  7. 6.2 Biocon
  8. 6.2.1 Biocon Company Information
  9. 6.2.2 Biocon Business Overview
  10. 6.2.3 Biocon Avastin (Bevacizumab) Biosimilars Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Biocon Avastin (Bevacizumab) Biosimilars Product Portfolio
  12. 6.2.5 Biocon Recent Developments
  13. 6.3 Cadila Pharmaceuticals
  14. 6.3.1 Cadila Pharmaceuticals Company Information
  15. 6.3.2 Cadila Pharmaceuticals Business Overview
  16. 6.3.3 Cadila Pharmaceuticals Avastin (Bevacizumab) Biosimilars Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Cadila Pharmaceuticals Avastin (Bevacizumab) Biosimilars Product Portfolio
  18. 6.3.5 Cadila Pharmaceuticals Recent Developments
  19. 6.4 Centus
  20. 6.4.1 Centus Company Information
  21. 6.4.2 Centus Business Overview
  22. 6.4.3 Centus Avastin (Bevacizumab) Biosimilars Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Centus Avastin (Bevacizumab) Biosimilars Product Portfolio
  24. 6.4.5 Centus Recent Developments
  25. 6.5 Dr Reddy's
  26. 6.5.1 Dr Reddy's Company Information
  27. 6.5.2 Dr Reddy's Business Overview
  28. 6.5.3 Dr Reddy's Avastin (Bevacizumab) Biosimilars Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Dr Reddy's Avastin (Bevacizumab) Biosimilars Product Portfolio
  30. 6.5.5 Dr Reddy's Recent Developments
  31. 6.6 Genentech
  32. 6.6.1 Genentech Company Information
  33. 6.6.2 Genentech Business Overview
  34. 6.6.3 Genentech Avastin (Bevacizumab) Biosimilars Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Genentech Avastin (Bevacizumab) Biosimilars Product Portfolio
  36. 6.6.5 Genentech Recent Developments
  37. 6.7 Hetero
  38. 6.7.1 Hetero Company Information
  39. 6.7.2 Hetero Business Overview
  40. 6.7.3 Hetero Avastin (Bevacizumab) Biosimilars Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Hetero Avastin (Bevacizumab) Biosimilars Product Portfolio
  42. 6.7.5 Hetero Recent Developments
  43. 6.8 Kirin Biologics
  44. 6.8.1 Kirin Biologics Company Information
  45. 6.8.2 Kirin Biologics Business Overview
  46. 6.8.3 Kirin Biologics Avastin (Bevacizumab) Biosimilars Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Kirin Biologics Avastin (Bevacizumab) Biosimilars Product Portfolio
  48. 6.8.5 Kirin Biologics Recent Developments
  49. 6.9 MAbxience
  50. 6.9.1 MAbxience Company Information
  51. 6.9.2 MAbxience Business Overview
  52. 6.9.3 MAbxience Avastin (Bevacizumab) Biosimilars Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 MAbxience Avastin (Bevacizumab) Biosimilars Product Portfolio
  54. 6.9.5 MAbxience Recent Developments
  55. 6.10 PharmaPraxis
  56. 6.10.1 PharmaPraxis Company Information
  57. 6.10.2 PharmaPraxis Business Overview
  58. 6.10.3 PharmaPraxis Avastin (Bevacizumab) Biosimilars Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 PharmaPraxis Avastin (Bevacizumab) Biosimilars Product Portfolio
  60. 6.10.5 PharmaPraxis Recent Developments
  61. 6.11 PlantForm
  62. 6.11.1 PlantForm Company Information
  63. 6.11.2 PlantForm Business Overview
  64. 6.11.3 PlantForm Avastin (Bevacizumab) Biosimilars Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 PlantForm Avastin (Bevacizumab) Biosimilars Product Portfolio
  66. 6.11.5 PlantForm Recent Developments
  67. 6.12 Samsung Bioepis
  68. 6.12.1 Samsung Bioepis Company Information
  69. 6.12.2 Samsung Bioepis Business Overview
  70. 6.12.3 Samsung Bioepis Avastin (Bevacizumab) Biosimilars Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Samsung Bioepis Avastin (Bevacizumab) Biosimilars Product Portfolio
  72. 6.12.5 Samsung Bioepis Recent Developments
  73. 6.13 Sartorius
  74. 6.13.1 Sartorius Company Information
  75. 6.13.2 Sartorius Business Overview
  76. 6.13.3 Sartorius Avastin (Bevacizumab) Biosimilars Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Sartorius Avastin (Bevacizumab) Biosimilars Product Portfolio
  78. 6.13.5 Sartorius Recent Developments
  79. 6.14 Amgen
  80. 6.14.1 Amgen Company Information
  81. 6.14.2 Amgen Business Overview
  82. 6.14.3 Amgen Avastin (Bevacizumab) Biosimilars Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Amgen Avastin (Bevacizumab) Biosimilars Product Portfolio
  84. 6.14.5 Amgen Recent Developments
  85. 6.15 BeiGene
  86. 6.15.1 BeiGene Company Information
  87. 6.15.2 BeiGene Business Overview
  88. 6.15.3 BeiGene Avastin (Bevacizumab) Biosimilars Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 BeiGene Avastin (Bevacizumab) Biosimilars Product Portfolio
  90. 6.15.5 BeiGene Recent Developments
  91. 6.16 Bayer
  92. 6.16.1 Bayer Company Information
  93. 6.16.2 Bayer Business Overview
  94. 6.16.3 Bayer Avastin (Bevacizumab) Biosimilars Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Bayer Avastin (Bevacizumab) Biosimilars Product Portfolio
  96. 6.16.5 Bayer Recent Developments
  97. 6.17 TOT BIOPHARM
  98. 6.17.1 TOT BIOPHARM Company Information
  99. 6.17.2 TOT BIOPHARM Business Overview
  100. 6.17.3 TOT BIOPHARM Avastin (Bevacizumab) Biosimilars Sales, Revenue and Gross Margin (2021-2026)
  101. 6.17.4 TOT BIOPHARM Avastin (Bevacizumab) Biosimilars Product Portfolio
  102. 6.17.5 TOT BIOPHARM Recent Developments
  103. 6.18 Henlius
  104. 6.18.1 Henlius Company Information
  105. 6.18.2 Henlius Business Overview
  106. 6.18.3 Henlius Avastin (Bevacizumab) Biosimilars Sales, Revenue and Gross Margin (2021-2026)
  107. 6.18.4 Henlius Avastin (Bevacizumab) Biosimilars Product Portfolio
  108. 6.18.5 Henlius Recent Developments
  109. 6.19 Pfizer
  110. 6.19.1 Pfizer Company Information
  111. 6.19.2 Pfizer Business Overview
  112. 6.19.3 Pfizer Avastin (Bevacizumab) Biosimilars Sales, Revenue and Gross Margin (2021-2026)
  113. 6.19.4 Pfizer Avastin (Bevacizumab) Biosimilars Product Portfolio
  114. 6.19.5 Pfizer Recent Developments
  115. 6.20 Eli Lilly
  116. 6.20.1 Eli Lilly Company Information
  117. 6.20.2 Eli Lilly Business Overview
  118. 6.20.3 Eli Lilly Avastin (Bevacizumab) Biosimilars Sales, Revenue and Gross Margin (2021-2026)
  119. 6.20.4 Eli Lilly Avastin (Bevacizumab) Biosimilars Product Portfolio
  120. 6.20.5 Eli Lilly Recent Developments
  121. 6.21 Roche
  122. 6.21.1 Roche Company Information
  123. 6.21.2 Roche Business Overview
  124. 6.21.3 Roche Avastin (Bevacizumab) Biosimilars Sales, Revenue and Gross Margin (2021-2026)
  125. 6.21.4 Roche Avastin (Bevacizumab) Biosimilars Product Portfolio
  126. 6.21.5 Roche Recent Developments
  127. 6.22 Luye Pharmaceutical
  128. 6.22.1 Luye Pharmaceutical Company Information
  129. 6.22.2 Luye Pharmaceutical Business Overview
  130. 6.22.3 Luye Pharmaceutical Avastin (Bevacizumab) Biosimilars Sales, Revenue and Gross Margin (2021-2026)
  131. 6.22.4 Luye Pharmaceutical Avastin (Bevacizumab) Biosimilars Product Portfolio
  132. 6.22.5 Luye Pharmaceutical Recent Developments
  133. 6.23 Mylan
  134. 6.23.1 Mylan Company Information
  135. 6.23.2 Mylan Business Overview
  136. 6.23.3 Mylan Avastin (Bevacizumab) Biosimilars Sales, Revenue and Gross Margin (2021-2026)
  137. 6.23.4 Mylan Avastin (Bevacizumab) Biosimilars Product Portfolio
  138. 6.23.5 Mylan Recent Developments
  139. 6.24 Qilu Pharmaceutical
  140. 6.24.1 Qilu Pharmaceutical Company Information
  141. 6.24.2 Qilu Pharmaceutical Business Overview
  142. 6.24.3 Qilu Pharmaceutical Avastin (Bevacizumab) Biosimilars Sales, Revenue and Gross Margin (2021-2026)
  143. 6.24.4 Qilu Pharmaceutical Avastin (Bevacizumab) Biosimilars Product Portfolio
  144. 6.24.5 Qilu Pharmaceutical Recent Developments
  145. 6.25 Innovent
  146. 6.25.1 Innovent Company Information
  147. 6.25.2 Innovent Business Overview
  148. 6.25.3 Innovent Avastin (Bevacizumab) Biosimilars Sales, Revenue and Gross Margin (2021-2026)
  149. 6.25.4 Innovent Avastin (Bevacizumab) Biosimilars Product Portfolio
  150. 6.25.5 Innovent Recent Developments
7 North America by Country
  1. 7.1 North America Avastin (Bevacizumab) Biosimilars Sales by Country
  2. 7.1.1 North America Avastin (Bevacizumab) Biosimilars Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Avastin (Bevacizumab) Biosimilars Sales by Country (2021-2026)
  4. 7.1.3 North America Avastin (Bevacizumab) Biosimilars Sales Forecast by Country (2027-2032)
  5. 7.2 North America Avastin (Bevacizumab) Biosimilars Market Size by Country
  6. 7.2.1 North America Avastin (Bevacizumab) Biosimilars Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Avastin (Bevacizumab) Biosimilars Market Size by Country (2021-2026)
  8. 7.2.3 North America Avastin (Bevacizumab) Biosimilars Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Avastin (Bevacizumab) Biosimilars Sales by Country
  2. 8.1.1 Europe Avastin (Bevacizumab) Biosimilars Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Avastin (Bevacizumab) Biosimilars Sales by Country (2021-2026)
  4. 8.1.3 Europe Avastin (Bevacizumab) Biosimilars Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Avastin (Bevacizumab) Biosimilars Market Size by Country
  6. 8.2.1 Europe Avastin (Bevacizumab) Biosimilars Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Avastin (Bevacizumab) Biosimilars Market Size by Country (2021-2026)
  8. 8.2.3 Europe Avastin (Bevacizumab) Biosimilars Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Avastin (Bevacizumab) Biosimilars Sales by Country
  2. 9.1.1 Asia-Pacific Avastin (Bevacizumab) Biosimilars Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Avastin (Bevacizumab) Biosimilars Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Avastin (Bevacizumab) Biosimilars Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Avastin (Bevacizumab) Biosimilars Market Size by Country
  6. 9.2.1 Asia-Pacific Avastin (Bevacizumab) Biosimilars Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Avastin (Bevacizumab) Biosimilars Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Avastin (Bevacizumab) Biosimilars Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Avastin (Bevacizumab) Biosimilars Sales by Country
  2. 10.1.1 South America Avastin (Bevacizumab) Biosimilars Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Avastin (Bevacizumab) Biosimilars Sales by Country (2021-2026)
  4. 10.1.3 South America Avastin (Bevacizumab) Biosimilars Sales Forecast by Country (2027-2032)
  5. 10.2 South America Avastin (Bevacizumab) Biosimilars Market Size by Country
  6. 10.2.1 South America Avastin (Bevacizumab) Biosimilars Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Avastin (Bevacizumab) Biosimilars Market Size by Country (2021-2026)
  8. 10.2.3 South America Avastin (Bevacizumab) Biosimilars Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Avastin (Bevacizumab) Biosimilars Sales by Country
  2. 11.1.1 Middle East and Africa Avastin (Bevacizumab) Biosimilars Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Avastin (Bevacizumab) Biosimilars Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Avastin (Bevacizumab) Biosimilars Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Avastin (Bevacizumab) Biosimilars Market Size by Country
  6. 11.2.1 Middle East and Africa Avastin (Bevacizumab) Biosimilars Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Avastin (Bevacizumab) Biosimilars Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Avastin (Bevacizumab) Biosimilars Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Avastin (Bevacizumab) Biosimilars Value Chain Analysis
  2. 12.1.1 Avastin (Bevacizumab) Biosimilars Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Avastin (Bevacizumab) Biosimilars Production Mode & Process
  7. 12.2 Avastin (Bevacizumab) Biosimilars Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Avastin (Bevacizumab) Biosimilars Distributors
  10. 12.2.3 Avastin (Bevacizumab) Biosimilars Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst